Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Israeli Transportation Company Dan Raising $11 Million In R&D Partnership IPO
Error: Contact form not found.
by Tzally Greenberg / CTech
An Egged public bus in Haifa, Israel. Photo: Wikimedia Commons.
CTech – Israel’s Dan public transportation bus company is setting up an R&D partnership focused on investing in startups in the smart mobility sector. Dan is aiming to raise NIS 36 million (approximately $11 million) through an initial public offering (IPO) on the Tel Aviv Stock Exchange. Value Base will underwrite the offering, with lawyers Itay Brafman and Adi Ron, partners at the Zeev Holender Law Office, providing legal guidance.
Dan has committed to acquiring 20% of the shares on the offering and will invest NIS 4.5 million in the partnership after it goes public, while also receiving an option to invest another NIS 7.5 million.
The partnership’s first investment is set to be in Israeli company Valerann at a sum of $2.7 million. Valerann, which has created a smart road solution for major highways, is being valued at $16 million in the deal, giving the R&D partnership a 12% stake in the company.
